This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta [TM]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo [TM]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 p...
- Carcinoma
- Adenocarcinoma
- Endometrial Neoplasms
- Cystadenocarcinoma, Serous
- Carcinoma, Endometrioid
- Carcinosarcoma
- Mixed Tumor, Mullerian
- Adenocarcinoma, Clear Cell
Age: 18 years - 66+
Gender: Female